Approved for Lacosamide is indicated for: • Treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) • Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 ). The precise mechanism by which lacosamide exerts its antiepileptic effects in humans remains to be fully elucidated. In vitro…
Loading full data from Know Your Drugs Institute…